Halozyme Therapeutics (HALO)
(Real Time Quote from BATS)
$50.92 USD
+5.27 (11.54%)
Updated Jun 6, 2024 11:43 AM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.74 |
EPS Last Quarter | 0.79 |
Last EPS Surprise | 14.49% |
ABR | 1.40 |
Earnings ESP
|
-0.72% |
---|---|
Current Year | 3.69 |
Next Year | 4.50 |
EPS (TTM) | 3.10 |
P/E (F1) | 12.36 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 200.06M | 255.76M | 951.42M | 1.10B |
# of Estimates | 5 | 5 | 5 | 6 |
High Estimate | 204.10M | 269.23M | 957.40M | 1.20B |
Low Estimate | 195.60M | 229.04M | 948.04M | 1.06B |
Year ago Sales | 221.04M | 216.03M | 829.25M | 951.42M |
Year over Year Growth Est. | -9.49% | 18.39% | 14.73% | 16.10% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.74 | 1.00 | 3.69 | 4.50 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | 0.80 | 1.09 | 3.89 | 4.76 |
High Estimate | 0.80 | 1.09 | 3.89 | 4.76 |
Low Estimate | 0.66 | 0.92 | 3.55 | 4.21 |
Year ago EPS | 0.74 | 0.75 | 2.77 | 3.69 |
Year over Year Growth Est. | 0.00% | 33.33% | 33.21% | 21.84% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 2 | 2 |
Up Last 60 Days | 2 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.74 | 1.00 | 3.69 | 4.50 |
7 Days Ago | 0.74 | 1.00 | 3.69 | 4.50 |
30 Days Ago | 0.73 | 0.99 | 3.66 | 4.50 |
60 Days Ago | 0.73 | 0.99 | 3.68 | 4.51 |
90 Days Ago | 0.81 | 1.00 | 3.67 | 4.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.74 | 1.06 | 3.73 | 4.54 |
Zacks Consensus Estimate | 0.74 | 1.00 | 3.69 | 4.50 |
Earnings ESP | -0.72% | 6.53% | 1.12% | 0.86% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.79 | 0.82 | 0.75 | 0.74 | NA |
Estimate | 0.69 | 0.82 | 0.71 | 0.63 | NA |
Difference | 0.10 | 0.00 | 0.04 | 0.11 | 0.06 |
Surprise | 14.49% | 0.00% | 5.63% | 17.46% | 9.40% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more